卵巢癌突变过程驱动特定部位的免疫逃避
Ignacio Vázquez-García1, Florian Uhlitz1, Nicholas Ceglia1
1Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Nature
|December 14, 2022
概括
高度血清性卵巢癌 (HGSOC) 根据其遗传突变和位置而有不同的发展. 这些因素影响瘤微环境,影响免疫反应和免疫疗法的有效性.
科学领域:
- 癌症学
- 基因组学
- 免疫学
背景情况:
- 高度血清性卵巢癌 (HGSOC) 的特征是基因组不稳定性,异质性和腹膜内传播.
- 当前免疫疗法在HGSOC的有效性有限,需要了解瘤微环境的驱动因素.
研究的目的:
- 研究突变过程和解剖瘤部位如何影响HGSOC的免疫状态.
- 确定HGSOC的进化表型分歧和免疫抵抗机制.
主要方法:
- 整体基因组测序,单细胞RNA测序,数字组织病理学和多重免疫光学的综合分析.
- 分析了42名未接受过治疗的HGSOC患者的160个瘤部位.
主要成果:
- 同类重组缺陷 (HRD) 瘤显示炎症信号,免疫编辑,HLA多样性丧失和CD8+ T细胞功能失调.
- 折叠逆转瘤表现出免疫抑制的TGFβ信号,免疫排除以及天真/干细胞和记忆T细胞.
- 瘤表型在附部和远部之间有显著的差异.
结论:
- 突变过程和解剖部位是HGSOC表型分歧和免疫抵抗的关键决定因素.
- 这些发现为开发个性化免疫疗法和HGSOC早期检测策略提供了多组数据基质.
相关概念视频
Tumor Immunotherapy
629
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
629
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Cancers Originate from Somatic Mutations in a Single Cell
12.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.4K
Cytotoxic T Cells-mediated Immune Response
1.1K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.1K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K


